| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.32B | 68.57B | 64.47B | 56.46B | 43.85B | 37.85B |
| Gross Profit | 15.82B | 15.55B | 14.60B | 12.55B | 9.51B | 7.86B |
| EBITDA | 2.71B | 3.03B | 2.45B | 1.30B | -307.00M | -1.54B |
| Net Income | 1.50B | 1.75B | 2.01B | 832.00M | -727.00M | -1.86B |
Balance Sheet | ||||||
| Total Assets | 22.93B | 22.97B | 24.86B | 20.79B | 17.67B | 17.94B |
| Cash, Cash Equivalents and Short-Term Investments | 4.14B | 4.01B | 6.51B | 4.22B | 3.54B | 4.38B |
| Total Debt | 1.50B | 1.78B | 4.56B | 4.88B | 6.38B | 6.93B |
| Total Liabilities | 14.84B | 15.04B | 18.20B | 16.35B | 14.90B | 14.45B |
| Stockholders Equity | 8.09B | 7.92B | 6.67B | 4.44B | 2.78B | 3.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 413.00M | 2.68B | 1.58B | -401.00M | -3.42B |
| Operating Cash Flow | 0.00 | 664.00M | 3.56B | 2.01B | -238.00M | -3.07B |
| Investing Cash Flow | 0.00 | -211.00M | -868.00M | -499.00M | 357.00M | -88.00M |
| Financing Cash Flow | 0.00 | -3.01B | -442.00M | -851.00M | -576.00M | 3.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥33.44B | 7.67 | ― | 1.93% | 6.11% | 15.68% | |
77 Outperform | ¥9.92B | 6.75 | ― | 0.71% | 7.40% | -5.83% | |
68 Neutral | ¥16.64B | 5.56 | ― | 3.17% | 5.19% | 11.04% | |
65 Neutral | ¥30.66B | 40.30 | ― | 3.23% | -0.31% | -37.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥51.27B | 11.15 | ― | 0.52% | 20.97% | -56.39% | |
61 Neutral | ¥9.37B | 24.88 | ― | 0.95% | 6.26% | 67.81% |